Perstorp invests in dynamic plastic materials market

Considerable investments have been made to deliver these new products that address key opportunities related to the use of plastics important to society today.

EnerPlastics extends its support to Dubai Cares by adopting a school in Gaza

The agreement was signed by Aman ur Rahman, Chief Executive Officer of EnerPlastics and Tariq Al Gurg, Chief Executive Officer of Dubai Cares.

China demand squeezes out other dairy buyers

Chinese supply crisis will delay international price adjustment, notes Rabobank Report: Global Dairy Industry Q3 2013

High acceptance for RePneu Coil

PneumRx's minimally invasive RePneu Coil becoming therapy of choice for patients with severe emphysema

Acoustic dispensing applied to mass spectrometry

Labcyte collaborates with AstraZeneca to develop acoustic sample handling for mass spectrometry to advance drug discovery

Hairstyling superstars at Asia's leading beauty event

Renowned celebrity stylists headline hair shows at Cosmoprof Asia 2013 on 13 & 14 November

APAC solid tumors market to reach $2.3 bn by 2019

Forecast growth due to ‘recent drug approvals and expected product launches for ovarian, pancreatic and prostate cancers,’ says GBI Research

Versatile wet/dry vacuum for healthcare facilities

Advance VL500 wet/dry vacuums provide versatile and cost-efficient cleaning performance

UK medical device market to reach $17.5 bn by 2020

British pharmaceutical market to reach $31.7 billion by 2020, GlobalData also forecasts

Real-time measurement of spinal cord myelin in MS

Breakthrough PET imaging technique provides essential molecular picture and offers first direct measurement of spinal cord myelin in multiple sclerosis (MS)

Smartphones have role in medical monitoring

Widespread adoption of mobile devices, even in low-resource settings, promises to make vital signs monitoring available anywhere and at low cost

Global type 2 diabetes market to reach $38.8 bn by 2019

Type 2 diabetes market to grow significantly and remain highly competitive as new drugs will have to ‘balance clinical efficacy with safety and tolerability profiles